Skip to content

Menu

ChannelsPublishersSubscribe
LexBlog, Inc. logo
LexBlog, Inc. logo
ProductsSub-MenuBlogsPortalsTwentySyndicationMicrositesResource Center
Join
Search
Close
Join the Movement. Blog 4 Good

ADA Asks for Incretin Mimetic Data

By Craig S. Hilliard on September 19, 2013
EmailTweetLikeLinkedIn

As we have previously reported, recent evidence suggests that incretin mimetic medications are linked to pancreatitis and pancreatic cancer. The American Diabetes Association (ADA) has asked all pharmaceutical companies involved in the development or marketing of incretin-based medications to make patient level data on their products available for an independent review. The ADA is concerned with the causal link between these medications, commonly sold as Byetta, Januvia/Janumet and Victoza, and pancreatitis and pancreatic cancer.

The ADA is calling all pharmaceutical companies with incretin therapies in development or currently marketed to make this patient-level data available.

If you or a loved one have suffered from pancreatitis or pancreatic cancer after taking Byetta, Januvia/Janumet or Victoza, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any potential claims.

Photo of Craig S. Hilliard Craig S. Hilliard

Craig S. Hilliard is a Shareholder in the Commercial Litigation Group and Chair of the Intellectual Property Litigation Group. He also serves as General Counsel to the law firm.

Read more about Craig S. HilliardEmail
  • Posted in:
    Civil Litigation, Class Action & Mass Torts
  • Blog:
    Mass Torts Law Blog
  • Organization:
    Stark & Stark
  • Article: View Original Source

Stay Connected

Facebook LinkedIn Twitter RSS
Real Lawyers

Company

  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service

Products

  • Products
  • Blogs
  • Portals
  • Twenty
  • Syndication
  • Microsites

Support

  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center

New to the Network

  • Red Clover Advisors Blog
  • Plane-ly Spoken
  • FCC Law Blog
  • California Employment Law
  • Privacy Compliance & Data Security
Copyright © 2021, LexBlog, Inc. All Rights Reserved.
Powered By LexBlog